Antibody-mediated protection against intracellular pathogens.

PubWeight™: 3.34‹?› | Rank: Top 1%

🔗 View Article (PMID 9582935)

Published in Trends Microbiol on March 01, 1998

Authors

A Casadevall1

Author Affiliations

1: Dept of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA. casadeva@aecom.yu.edu

Articles citing this

Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells. Infect Immun (2000) 2.53

The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children. J Clin Invest (2008) 2.35

A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection. J Immunol (2005) 2.26

A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival. Proc Natl Acad Sci U S A (1998) 2.13

Antibody is required for protection against virulent but not attenuated Salmonella enterica serovar typhimurium. Infect Immun (2000) 1.88

Serum therapy for tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis. Clin Microbiol Rev (1998) 1.82

Intracellular pathogens: the role of antibody-mediated protection in Salmonella infection. Trends Microbiol (1998) 1.73

Igh-6(-/-) (B-cell-deficient) mice fail to mount solid acquired resistance to oral challenge with virulent Salmonella enterica serovar typhimurium and show impaired Th1 T-cell responses to Salmonella antigens. Infect Immun (2000) 1.67

Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum. J Clin Invest (2003) 1.60

Characterization of Francisella tularensis outer membrane proteins. J Bacteriol (2006) 1.59

The protective role of antibody responses during Mycobacterium tuberculosis infection. Clin Exp Immunol (2009) 1.48

Antibody-mediated elimination of the obligate intracellular bacterial pathogen Ehrlichia chaffeensis during active infection. Infect Immun (2000) 1.44

Monoclonal antibodies to heat shock protein 60 alter the pathogenesis of Histoplasma capsulatum. Infect Immun (2009) 1.36

Utilization of Fc receptors as a mucosal vaccine strategy against an intracellular bacterium, Francisella tularensis. J Immunol (2008) 1.36

Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs. Immunology (2004) 1.31

Antibody-mediated immunity against intracellular pathogens: two-dimensional thinking comes full circle. Infect Immun (2003) 1.29

Intranasal vaccination with a defined attenuated Francisella novicida strain induces gamma interferon-dependent antibody-mediated protection against tularemia. Infect Immun (2006) 1.27

Survival, replication, and antibody susceptibility of Ehrlichia chaffeensis outside of host cells. Infect Immun (2003) 1.23

T-Cell-independent humoral immunity is sufficient for protection against fatal intracellular ehrlichia infection. Infect Immun (2007) 1.22

Essential role for humoral immunity during Ehrlichia infection in immunocompetent mice. Infect Immun (2005) 1.12

Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis. PLoS One (2009) 1.10

CD4+ T cells and antibody are required for optimal major outer membrane protein vaccine-induced immunity to Chlamydia muridarum genital infection. Infect Immun (2010) 1.08

Therapeutic efficacy of high-dose intravenous immunoglobulin in Mycobacterium tuberculosis infection in mice. Infect Immun (2005) 1.06

Clinical and Immunological Analysis of Cutaneous Leishmaniasis before and after Different Treatments. J Parasitol Res (2013) 0.98

Intracellular neutralization of viral infection in polarized epithelial cells by neonatal Fc receptor (FcRn)-mediated IgG transport. Proc Natl Acad Sci U S A (2011) 0.97

Antibody therapy for histoplasmosis. Front Microbiol (2012) 0.96

Immune response regulation by leishmania secreted and nonsecreted antigens. J Biomed Biotechnol (2007) 0.95

Characterization of immunoglobulin G and its subclass response to Indian kala-azar infection before and after chemotherapy. Infect Immun (2004) 0.90

Immunogenicity of the P-8 amastigote antigen in the experimental model of canine visceral leishmaniasis. Vaccine (2006) 0.88

Characterization of a novel inactivated Salmonella enterica serovar Enteritidis vaccine candidate generated using a modified cI857/λ PR/gene E expression system. Infect Immun (2012) 0.85

Salmonella Typhimurium induces SPI-1 and SPI-2 regulated and strain dependent downregulation of MHC II expression on porcine alveolar macrophages. Vet Res (2012) 0.84

Molecular basis of antibody mediated immunity against Ehrlichia chaffeensis involves species-specific linear epitopes in tandem repeat proteins. Microbes Infect (2012) 0.83

Leishmania cytosolic silent information regulatory protein 2 deacetylase induces murine B-cell differentiation and in vivo production of specific antibodies. Immunology (2006) 0.83

Fc receptor-targeting of immunogen as a strategy for enhanced antigen loading, vaccination, and protection using intranasally administered antigen-pulsed dendritic cells. Vaccine (2014) 0.80

Role of B cells and antibodies in acquired immunity against Mycobacterium tuberculosis. Cold Spring Harb Perspect Med (2014) 0.80

Antibody targeting the ferritin-like protein controls Listeria infection. Infect Immun (2010) 0.80

Functional Activity of Antibodies Directed towards Flagellin Proteins of Non-Typhoidal Salmonella. PLoS One (2016) 0.78

Comparative molecular dynamics studies of heterozygous open reading frames of DNA polymerase eta (η) in pathogenic yeast Candida albicans. Sci Rep (2017) 0.75

Vaccination against intracellular bacterial pathogens. Trends Microbiol (1998) 0.75